c.batista
Submits third-party assay reports on material purchased directly. Based in Kraków.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.84%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041648 | SS-31 (Elamipretide) | FGP | FGP-2601-R8955 | Janoshik | 2026-Q2 | 98.45 | 3.95 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042935 | Selank | MKM | MKM-2512-T3523 | Nordanalyt | 2026-Q1 | 99.84 | 8.06 | 90.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020940 | Semaglutide | WXT | WXT-2508-G2836 | Medutest | 2025-Q3 | 98.86 | 3.15 | 89.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018495 | MOTS-c | WWB | WWB-2505-G2801 | VendorInvestigate | 2025-Q3 | 99.56 | 2.94 | 89.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004345 | CJC-1295 (no DAC) | FGP | FGP-2410-J7714 | VendorInvestigate | 2024-Q4 | 99.68 | 4.65 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005355 | MK-677 (Ibutamoren mesylate) | SIG | SIG-2404-6898 | Janoshik | 2024-Q3 | 98.82 | 3.54 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004437 | Semaglutide | GSP | GSP-2405-W3331 | Medutest | 2024-Q2 | 98.53 | 3.25 | 105.5 | Buyer-sourced | 0 | PASS |
| AX-2024-004652 | Retatrutide | TFC | TFC-2309-H2397 | PeptideMeter | 2024-Q1 | 98.63 | 4.14 | — | Buyer-sourced | 0 | PASS |